SE2251224A1 - Water purification involving an electro-peroxone process - Google Patents
Water purification involving an electro-peroxone processInfo
- Publication number
- SE2251224A1 SE2251224A1 SE2251224A SE2251224A SE2251224A1 SE 2251224 A1 SE2251224 A1 SE 2251224A1 SE 2251224 A SE2251224 A SE 2251224A SE 2251224 A SE2251224 A SE 2251224A SE 2251224 A1 SE2251224 A1 SE 2251224A1
- Authority
- SE
- Sweden
- Prior art keywords
- water
- reaction vessel
- flow path
- inlet
- vessel
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 293
- 238000000034 method Methods 0.000 title claims abstract description 63
- 238000000746 purification Methods 0.000 title claims abstract description 31
- 230000008569 process Effects 0.000 title abstract description 19
- 238000006243 chemical reaction Methods 0.000 claims abstract description 180
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000001301 oxygen Substances 0.000 claims abstract description 31
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 31
- 239000003792 electrolyte Substances 0.000 claims abstract description 15
- 230000005611 electricity Effects 0.000 claims abstract description 10
- 238000011065 in-situ storage Methods 0.000 claims abstract description 6
- 239000007789 gas Substances 0.000 claims description 24
- 239000012530 fluid Substances 0.000 claims description 17
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 16
- 238000002347 injection Methods 0.000 claims description 15
- 239000007924 injection Substances 0.000 claims description 15
- 238000011144 upstream manufacturing Methods 0.000 claims description 15
- 229910052799 carbon Inorganic materials 0.000 claims description 14
- 239000002351 wastewater Substances 0.000 claims description 13
- -1 carbon-polytetrafluoroethylene Chemical class 0.000 claims description 12
- 238000009792 diffusion process Methods 0.000 claims description 10
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 10
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 10
- 239000003651 drinking water Substances 0.000 claims description 8
- 235000020188 drinking water Nutrition 0.000 claims description 8
- 238000006722 reduction reaction Methods 0.000 claims description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 6
- 230000003068 static effect Effects 0.000 claims description 6
- 239000004744 fabric Substances 0.000 claims description 5
- 229910052719 titanium Inorganic materials 0.000 claims description 5
- UTBVIMLZIRIFFR-UHFFFAOYSA-N 2-methylthio-1,3-benzothiazole Chemical compound C1=CC=C2SC(SC)=NC2=C1 UTBVIMLZIRIFFR-UHFFFAOYSA-N 0.000 claims description 4
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims description 4
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 claims description 4
- 239000003139 biocide Substances 0.000 claims description 4
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 claims description 4
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 claims description 4
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 claims description 4
- 229960001259 diclofenac Drugs 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000002352 surface water Substances 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 3
- 239000010865 sewage Substances 0.000 claims description 3
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 claims description 2
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 claims description 2
- METKIMKYRPQLGS-GFCCVEGCSA-N (R)-atenolol Chemical compound CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-GFCCVEGCSA-N 0.000 claims description 2
- WSEQXVZVJXJVFP-HXUWFJFHSA-N (R)-citalopram Chemical compound C1([C@@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-HXUWFJFHSA-N 0.000 claims description 2
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 claims description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- 239000003315 2-(4-chlorophenoxy)-2-methylpropanoic acid Substances 0.000 claims description 2
- LFYXNXGVLGKVCJ-FBIMIBRVSA-N 2-methylisoborneol Chemical compound C1C[C@@]2(C)[C@](C)(O)C[C@@H]1C2(C)C LFYXNXGVLGKVCJ-FBIMIBRVSA-N 0.000 claims description 2
- LFYXNXGVLGKVCJ-UHFFFAOYSA-N 2-methylisoborneol Natural products C1CC2(C)C(C)(O)CC1C2(C)C LFYXNXGVLGKVCJ-UHFFFAOYSA-N 0.000 claims description 2
- CMGDVUCDZOBDNL-UHFFFAOYSA-N 4-methyl-2h-benzotriazole Chemical compound CC1=CC=CC2=NNN=C12 CMGDVUCDZOBDNL-UHFFFAOYSA-N 0.000 claims description 2
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 claims description 2
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 claims description 2
- 239000002947 C09CA04 - Irbesartan Substances 0.000 claims description 2
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 claims description 2
- DJBNUMBKLMJRSA-UHFFFAOYSA-N Flecainide Chemical compound FC(F)(F)COC1=CC=C(OCC(F)(F)F)C(C(=O)NCC2NCCCC2)=C1 DJBNUMBKLMJRSA-UHFFFAOYSA-N 0.000 claims description 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 claims description 2
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 claims description 2
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 claims description 2
- 239000005822 Propiconazole Substances 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 229960002274 atenolol Drugs 0.000 claims description 2
- 229960005370 atorvastatin Drugs 0.000 claims description 2
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 claims description 2
- IIBYAHWJQTYFKB-UHFFFAOYSA-N bezafibrate Chemical compound C1=CC(OC(C)(C)C(O)=O)=CC=C1CCNC(=O)C1=CC=C(Cl)C=C1 IIBYAHWJQTYFKB-UHFFFAOYSA-N 0.000 claims description 2
- 229960000516 bezafibrate Drugs 0.000 claims description 2
- VHYCDWMUTMEGQY-UHFFFAOYSA-N bisoprolol Chemical compound CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1 VHYCDWMUTMEGQY-UHFFFAOYSA-N 0.000 claims description 2
- 229960002781 bisoprolol Drugs 0.000 claims description 2
- SNPPWIUOZRMYNY-UHFFFAOYSA-N bupropion Chemical compound CC(C)(C)NC(C)C(=O)C1=CC=CC(Cl)=C1 SNPPWIUOZRMYNY-UHFFFAOYSA-N 0.000 claims description 2
- 229960001058 bupropion Drugs 0.000 claims description 2
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 claims description 2
- 229960000623 carbamazepine Drugs 0.000 claims description 2
- 229960001803 cetirizine Drugs 0.000 claims description 2
- IPPWILKGXFOXHO-UHFFFAOYSA-N chloranilic acid Chemical compound OC1=C(Cl)C(=O)C(O)=C(Cl)C1=O IPPWILKGXFOXHO-UHFFFAOYSA-N 0.000 claims description 2
- 229960003405 ciprofloxacin Drugs 0.000 claims description 2
- 229960001653 citalopram Drugs 0.000 claims description 2
- 229960002626 clarithromycin Drugs 0.000 claims description 2
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 claims description 2
- 229960002227 clindamycin Drugs 0.000 claims description 2
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 claims description 2
- TXCGAZHTZHNUAI-UHFFFAOYSA-N clofibric acid Chemical compound OC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 TXCGAZHTZHNUAI-UHFFFAOYSA-N 0.000 claims description 2
- 229950008441 clofibric acid Drugs 0.000 claims description 2
- 229960004022 clotrimazole Drugs 0.000 claims description 2
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 claims description 2
- 229960004126 codeine Drugs 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims description 2
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 claims description 2
- 229960003529 diazepam Drugs 0.000 claims description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 229960003276 erythromycin Drugs 0.000 claims description 2
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 claims description 2
- 229960003592 fexofenadine Drugs 0.000 claims description 2
- 229960000449 flecainide Drugs 0.000 claims description 2
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 claims description 2
- 229960004884 fluconazole Drugs 0.000 claims description 2
- 229910021397 glassy carbon Inorganic materials 0.000 claims description 2
- 229910002804 graphite Inorganic materials 0.000 claims description 2
- 239000010439 graphite Substances 0.000 claims description 2
- 239000003673 groundwater Substances 0.000 claims description 2
- 229930195733 hydrocarbon Natural products 0.000 claims description 2
- 150000002430 hydrocarbons Chemical class 0.000 claims description 2
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 claims description 2
- 229960001680 ibuprofen Drugs 0.000 claims description 2
- 239000010842 industrial wastewater Substances 0.000 claims description 2
- DGAIEPBNLOQYER-UHFFFAOYSA-N iopromide Chemical compound COCC(=O)NC1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)N(C)CC(O)CO)=C1I DGAIEPBNLOQYER-UHFFFAOYSA-N 0.000 claims description 2
- 229960002603 iopromide Drugs 0.000 claims description 2
- YCPOHTHPUREGFM-UHFFFAOYSA-N irbesartan Chemical compound O=C1N(CC=2C=CC(=CC=2)C=2C(=CC=CC=2)C=2[N]N=NN=2)C(CCCC)=NC21CCCC2 YCPOHTHPUREGFM-UHFFFAOYSA-N 0.000 claims description 2
- 229960002198 irbesartan Drugs 0.000 claims description 2
- 229960004125 ketoconazole Drugs 0.000 claims description 2
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 claims description 2
- 229960003088 loratadine Drugs 0.000 claims description 2
- 229960000485 methotrexate Drugs 0.000 claims description 2
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 claims description 2
- 229960002237 metoprolol Drugs 0.000 claims description 2
- 229960000282 metronidazole Drugs 0.000 claims description 2
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 claims description 2
- 229960002509 miconazole Drugs 0.000 claims description 2
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 claims description 2
- 229960001785 mirtazapine Drugs 0.000 claims description 2
- 229960002009 naproxen Drugs 0.000 claims description 2
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims description 2
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 claims description 2
- 229960001180 norfloxacin Drugs 0.000 claims description 2
- 235000006408 oxalic acid Nutrition 0.000 claims description 2
- ADIMAYPTOBDMTL-UHFFFAOYSA-N oxazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(O)N=C1C1=CC=CC=C1 ADIMAYPTOBDMTL-UHFFFAOYSA-N 0.000 claims description 2
- 229960004535 oxazepam Drugs 0.000 claims description 2
- 244000052769 pathogen Species 0.000 claims description 2
- XDRYMKDFEDOLFX-UHFFFAOYSA-N pentamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCOC1=CC=C(C(N)=N)C=C1 XDRYMKDFEDOLFX-UHFFFAOYSA-N 0.000 claims description 2
- 229960004448 pentamidine Drugs 0.000 claims description 2
- 239000000575 pesticide Substances 0.000 claims description 2
- 239000003209 petroleum derivative Substances 0.000 claims description 2
- 150000002989 phenols Chemical class 0.000 claims description 2
- 125000005498 phthalate group Chemical class 0.000 claims description 2
- 229910052697 platinum Inorganic materials 0.000 claims description 2
- 150000003071 polychlorinated biphenyls Chemical class 0.000 claims description 2
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 claims description 2
- DQMZLTXERSFNPB-UHFFFAOYSA-N primidone Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NCNC1=O DQMZLTXERSFNPB-UHFFFAOYSA-N 0.000 claims description 2
- 229960002393 primidone Drugs 0.000 claims description 2
- STJLVHWMYQXCPB-UHFFFAOYSA-N propiconazole Chemical compound O1C(CCC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 STJLVHWMYQXCPB-UHFFFAOYSA-N 0.000 claims description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 claims description 2
- 229960000620 ranitidine Drugs 0.000 claims description 2
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 claims description 2
- 229910052707 ruthenium Inorganic materials 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 229960005404 sulfamethoxazole Drugs 0.000 claims description 2
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 229960000195 terbutaline Drugs 0.000 claims description 2
- 229950011008 tetrachloroethylene Drugs 0.000 claims description 2
- 229960004380 tramadol Drugs 0.000 claims description 2
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 claims description 2
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 claims description 2
- 229960001082 trimethoprim Drugs 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- 229920000049 Carbon (fiber) Polymers 0.000 claims 1
- 239000004917 carbon fiber Substances 0.000 claims 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract description 19
- 230000015572 biosynthetic process Effects 0.000 abstract description 11
- 238000006385 ozonation reaction Methods 0.000 abstract description 10
- 239000007788 liquid Substances 0.000 abstract description 6
- 238000013461 design Methods 0.000 abstract description 4
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 45
- 230000008901 benefit Effects 0.000 description 6
- 239000011244 liquid electrolyte Substances 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000009303 advanced oxidation process reaction Methods 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- WOCIAKWEIIZHES-UHFFFAOYSA-N ruthenium(iv) oxide Chemical compound O=[Ru]=O WOCIAKWEIIZHES-UHFFFAOYSA-N 0.000 description 4
- 239000010936 titanium Substances 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 229910001882 dioxygen Inorganic materials 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000005446 dissolved organic matter Substances 0.000 description 2
- 238000005868 electrolysis reaction Methods 0.000 description 2
- 239000003014 ion exchange membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 229910000838 Al alloy Inorganic materials 0.000 description 1
- 229910000881 Cu alloy Inorganic materials 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 229910001297 Zn alloy Inorganic materials 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000003317 industrial substance Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 229910001251 solid state electrolyte alloy Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
- C25B1/00—Electrolytic production of inorganic compounds or non-metals
- C25B1/01—Products
- C25B1/28—Per-compounds
- C25B1/30—Peroxides
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/467—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis by electrochemical disinfection; by electrooxydation or by electroreduction
- C02F1/4672—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis by electrochemical disinfection; by electrooxydation or by electroreduction by electrooxydation
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/72—Treatment of water, waste water, or sewage by oxidation
- C02F1/78—Treatment of water, waste water, or sewage by oxidation with ozone
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/72—Treatment of water, waste water, or sewage by oxidation
- C02F1/722—Oxidation by peroxides
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/46104—Devices therefor; Their operating or servicing
- C02F1/46109—Electrodes
- C02F2001/46152—Electrodes characterised by the shape or form
- C02F2001/46157—Perforated or foraminous electrodes
- C02F2001/46161—Porous electrodes
- C02F2001/46166—Gas diffusion electrodes
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Electrochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Metallurgy (AREA)
- Treatment Of Water By Oxidation Or Reduction (AREA)
- Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
- Water Treatment By Electricity Or Magnetism (AREA)
Abstract
Abstract The invention relates to a system and a method for purification of water suitable for large scale water purification, utilizing ozonation in combination with in situ electrochemical formation of hydrogen peroxide to form an electro-peroxone process, wherein the process design is configured to result in scalable, efficient and durable water purification with use of oxygen, water and electricity, and without addition of liquid Hfib. The system comprises a reaction vessel and a separate electrochemical cell, the cell comprising a cathode, an anode and a solid-state electrolyte as well as an inlet for clean water.
Description
Technical Field of the Invention
The invention relates to the technical field of water purification. More specifically, the present invention relates to a system and a method for water purification comprising addition of ozone and hydrogen peroxide generated by a process involving electricity, oxygen and clean water.
Background
Occurrence of micropollutants (MPs) including pharmaceuticals, biocides, personal care products and industrial chemicals in wastewaters is a major challenge which poses a potential threat to aquatic ecosystems as well as to humans. Occurrence of MPs in different water systems including surface water, sea water and drinking water (if surface water is used as a source of drinking water) is mainly related to the discharge from wastewater treatment plants (WWTPs). This is because conventional WWTPs are not designed to remove MPs. The low concentration and diverse nature of MPs complicate their removal at WWTPs. There is an imperative need for a treatment process capable of removing MPs of complex and diverse nature
from wastewaters and other contaminated waters.
Advanced oxidation processes (AOPs) have gained interest in the last two decades due to their effectiveness for removal of MPs in various waters. One advantageous AOP is the ozonation process due to the selective nature of ozone for removing MPs and the possibility to handle large volumes of wastewater. MPs are oxidized by ozone and hydroxyl radicals (°OH) during ozonation. Ozone is a selective oxidant and transforms MPs
into other small molecular weight compounds by oxidizing their
double bonds and other electron rich moieties, selectively. -OH have higher oxidizing potential (2.8 eV) than ozone (2.l eV) and oxidatively degrades almost all organic MPs present in the water non-selectively at very high rate. However, formation of -OH in ozonation is dependent upon ozone reaction with dissolved organic matter (DOM) and other water constituents and often -OH formation is slow for ozonation. This leads to poor removal of ozone-resistant MPs that lack double bonds or electron rich moieties for electrophilic ozone attack as these ozone-resistant MPs are oxidized by -OH. Thus, accelerating formation of -OH is advantageous and required for achieving better water quality by removing ozone-resistant
MPs.
For effective removal of ozone-resistant MPs, ozonation can be upgraded to another process called peroxone, where hydrogen peroxide (Hfib) is provided externally together with ozone to accelerate the formation of -OH. However, providing Hfib externally is not always practically feasible, involves risky handling of liquid Hfib and increases the cost substantially. Continuous transportation of Hfib on-site and its handling are big challenges in application. To overcome these challenges, an electrochemical advanced oxidation process, called electro- peroxone is developed. In the electro-peroxone process, Hflb is generated in-situ electrochemically at cathode via oxygen reduction reaction. Generated Hflb mixes homogeneously in the solution and enhances transformation of ozone (by reacting with it) into -OH. As a result, formation of -OH is
accelerated which improves the removal of ozone-resistant MPs.
Removal of resistant MPs via effective formation of -OH in a
continuous industrial and large scale electro-peroxone process
requires a correct system design as well as appropriate electrode materials for robust electrochemical generation of
Hflb, which has been lacking in previous works.
US 2020/0055754A1 discloses a reaction vessel where ozone is injected from the bottom of the reaction vessel whereas cathode and anode electrodes are suggested to be placed in the upper part of the same reaction vessel in the main water flow. Ozone generator effluent which consists of ozone and oxygen Mb/Og) gas can be guided to the electrodes using a current plate below the electrolysis electrodes pair for generation of
H2O2.
Bulk in situ electrochemical generation of Hfib in the electro- peroxone process is a key step which depends on the mass transfer of O2 to the cathode for oxygen reduction reaction. In a traditional setting with submerged electrodes, the electrodes are directly submerged in electrolytes and these electrolytes are aerated with oxygen gas (in the reaction vessel). Due to the low solubility of oxygen in water, the mass transfer of oxygen to the submerged electrodes is low which in turn limits the achievable current density to a few mA/cm? and limited generation of Hfib. One way of solving this problem is using an electrochemical cell with small water flow (separated from the main water flow) which enables high mass transfer of O2 to the cathode, using for instance gas diffusion electrodes. High mass transfer of oxygen to the cathode enables it to use high current densities for oxygen reduction reaction, in turn high concentration of Hfib can be achieved in a smaller liquid volume and injected into the main water
stream.
(Yang Li, Yixin Zhang, Guangshen Xia, Juhong Zhan, Gang Yu, Yujue Wang. 2021, Evaluation of the technoeconomic feasibility of electrochemical hydrogen peroxide production for decentralized water treatment. Front. Environ. Sci. Eng. 2021, l5(l): l) used a similar approach with gas diffusion electrodes and achieved current density as high as 400 mA/cm2. This study used liquid electrolyte in an electrochemical cell
for generation of H2O2.
EP 3430182 Bl discloses an electrochemical cell with improved properties for production of Hflb and suggested to incorporate the Hfib with ozone addition. However, no information is
provided of the reactor design including the wastewater flows
for treatment and ozone and hydrogen peroxide addition.
KR 20l90l20837 A discloses an electro-peroxone based water treatment device. The wastewater is first mixed with ozone and then treated in a reactor comprising electrodes to generate
hydrogen peroxone and then circulated again to the system.
US 2020262723 Al discloses a method for removing contaminants in a water treatment process by introducing a mixture of 02 and 03 gas into an ozone reaction column in which electrodes are
disposed at the bottom.
Summary of the invention
One object of the present invention is to obviate at least some of the problems in the prior art and provide a system and a method for purification of water that can handle large flows
of water.
More specifically, the invention relates to a system and a method for purification of water suitable for large scale water purification, utilizing ozonation in combination with in situ electrochemical formation of hydrogen peroxide to form an electro-peroxone process, wherein the process design is configured to result in scalable, efficient and durable water purification with use of oxygen, water and electricity, and
without addition of liquid Hfib.
According to a first aspect, there is provided a water treatment system for purification of water, said system
comprising: a. a reaction vessel 110 comprising
- a first vessel inlet 113 for water to be treated
to enter said reaction vessel 110,
- a first vessel outlet 111 for treated water to
exit said reaction vessel 110,
- a second vessel outlet 112 for gas to exit said reaction vessel 110, said second outlet 112 being located in
an upper part of said reaction vessel 110, and
- a second vessel inlet 121 for supplying 03 to the reaction vessel 110, said second inlet 121 being located in a
lower part of said reaction vessel 110,
b. a main water line 150 leading from a main inlet 118 for
water to be treated to said first vessel inlet 113, and
c. an electrochemical cell 130 for Hflb generation comprising at least one cathode, at least one anode and a solid-state
electrolyte,
said electrochemical cell 130 having an oxygen inlet 131 and a
clean water inlet 132,
said electrochemical cell 130 being adapted to be connected
with a source of electricity 133, and
said electrochemical cell having an outlet enabling said electrochemical cell 130 to be in fluid connection with said
reaction vessel 110 through at least one Hfib inlet point 115.
According to a second aspect, there is provided a method for
purification of water, the method comprising the steps of:
- supplying clean water, oxygen and electricity to at least one electrochemical cell 130, said at least one electro- chemical cell 130 comprising of at least one cathode, at least one anode and a solid-state electrolyte, whereby Hflb is generated in situ electrochemically when oxygen undergoes an oxygen reduction reaction on the surface of the at least one
cathode,
- supplying water comprising Hflb from said electrochemical
cell 130 into a reaction vessel 110,
- supplying water to be treated into the reaction vessel 110 through a water main line 150 which enters the reaction vessel
110 through a first vessel inlet 113, - introducing O3 into a lower part of said reaction vessel 110, - releasing gas from said reaction vessel 110, and
- releasing treated water from said reaction vessel 110.
An advantage of using an electrochemical cell 130 for Hfib generation which is separate from the reaction vessel 110 is an improved ability to provide availability of oxygen to the at least one cathode and thereby use of high current
densities. As a result, high concentration of Hflb can be
achieved in a smaller volume of water before injecting it into
the water to be treated.
Another advantage of the electrochemical cell 130 being separate from the reaction vessel 110 and having a clean water inlet 132 through which clean water is supplied to the electrochemical cell 130 is that the Hfib generation takes place using clean water, thereby avoiding formation of potential toxic byproducts which usually form during electrochemical processes when using e.g. wastewater as a
SOUICG .
By using a solid-state electrolyte, handling of liquid
electrolytes is avoided.
Brief description of the drawings
Aspects and embodiments will be described with reference to
the following drawings in which:
Figure 1 is an overview of a specific embodiment of a water purification system wherein ozone is injected into a reaction
vessel 110 through diffusers 114.
Figure 2 is an overview of a specific embodiment of a water purification system wherein ozone is injected into a first flow path 151 for water through a venturi injector, wherein the first flow path 151 has a source of water other than that
of a main water line 150.
Figure 3 is an overview of a specific embodiment of a water purification system wherein ozone is injected into a first flow path 151 for water through a venturi injector, wherein the source of water for the first flow path 151 is the main
water line 150 for water to be treated.
Figure 4 is an overview of a specific embodiment of a water purification system wherein ozone is injected into a first flow path 151 for water through a venturi injector, wherein the source of water for the first flow path 151 is the main water line 150 for water to be treated, and wherein the water comprising Hflb is injected to the water main line 150 at an Hflb inlet point 115 via a second flow path 152 using a venturi
injector.
Figure 5 is an overview of a specific embodiment of a water purification system wherein ozone is added both through a venturi injector into a first flow path 151 which enters the main water line 150 and also through diffusers 114 which are located in a lower part of the reaction vessel 110, and wherein the water comprising Hfib is injected to the water main line 150 at an Hflb inlet point 115 via a second flow path 152
using a venturi injector.
Detailed description
Before the invention is disclosed and described in detail, it is to be understood that this invention is not limited to particular configurations, process steps and materials disclosed herein as such configurations, process steps and materials may vary somewhat. It is also to be understood that the terminology employed herein is used for the purpose of
describing particular embodiments only and is not intended to
be limiting since the scope of the present invention is
limited only by the appended claims and equivalents thereof.
It will be apparent to those skilled in the art that various modifications and variations can be made to the system and method of the present disclosure without departing from the scope of the disclosure. Other embodiments will be apparent to those skilled in the art from consideration of the specification and practice of the system and method disclosed herein. The features of the different embodiments which are compatible may be combined in different ways that are not specifically disclosed by example. It is intended that the specification and examples be considered as exemplary only, with a true scope of the disclosure being indicated by the
following claims and their equivalent.
It must be noted that, as used in this specification and the
\\ \\
a", an
l/
appended claims, the singular forms and “the” include plural referents unless the context clearly dictates
otherwise.
If nothing else is defined, any terms and scientific terminology used herein are intended to have the meanings commonly understood by those of skill in the art to which this
invention pertains.
As used throughout the claims and the description, the term “reaction vessel” denotes a device where an electro-peroxone reaction is intended to take place. The vessel has a volume where water comprising hydrogen peroxide can react with O3in
the water. In some embodiments of the invention, such a
reaction also takes place at locations in the system outside
of the reaction vessel.
As used throughout the claims and the description, the term “electrochemical cell” denotes a device where Hflb is generated, having at least one cathode and at least one anode which are connected to a voltage supply to supply a suitable
current. The electrodes are provided with oxygen and water.
The oxygen supplied to the electrochemical cell may be in the form of O2 (oxygen gas) or air. Oxygen gas may be preferred as it is generally more efficient to use, while air may be
preferred as it is convenient to use due to availability.
The term “water line” or “flow path” denotes a path of connected volumes such as the inner volumes of pipes, chambers and so on in a device where water can flow in a certain direction from one part to another part. Examples include
pipes, tubes, and chambers.
The term “upstream” denotes a location situated in the opposite direction from that in which liquid flows, referring to the intended direction of water in the flow path. A position upstream is nearer to the source of the liquid, compared to a given location and following the flow path. In the system there are intended paths for water along which water is designed to flow. Such a path may be divided to several paths which may then optionally rejoin to fewer paths.
Upstream is always opposite the direction of the flow.
11
The term “clean water” denotes water other than water intended to be purified, i.e. not comprising high content of DOC and contaminants intended to be removed through the treatment process. Examples of clean water include DI water, drinking
water, tap water, or high quality water.
The terms “upper” and “lower” denote locations in the system as it is intended to be oriented when the system is in position for use. An upper part is situated in a physical position vertically above a lower part with regards to the
direction of the gravitational force.
In a first aspect, there is provided a water treatment system
for purification of water, said system comprising: a. a reaction vessel 110 comprising
- a first vessel inlet 113 for water to be treated
to enter said reaction vessel 110,
- a first vessel outlet 111 for treated water to
exit said reaction vessel 110,
- a second vessel outlet 112 for gas to exit said reaction vessel 110, said second outlet 112 being located in
an upper part of said reaction vessel 110, and
- a second vessel inlet 121 for supplying 03 to the reaction vessel 110, said second inlet 121 being located in a
lower part of said reaction vessel 110,
b. a main water line 150 leading from a main inlet 118 for
water to be treated to said first vessel inlet 113, and
c. an electrochemical cell 130 for Hflb generation comprising of at least one cathode, at least one anode and a solid-state
electrolyte,
12
said electrochemical cell 130 having an oxygen inlet 131 and a
clean water inlet 132,
said electrochemical cell 130 being adapted to be connected
with a source of electricity 133, and
said electrochemical cell having an outlet enabling said electrochemical cell 130 to be in fluid connection with said
reaction vessel 110 through at least one Hfib inlet point 115.
Placing the electrodes directly in the reaction vessel 110, which contains a volume larger than the electrolysis cell 130, would require a very large cathode, or several cathodes, to generate sufficient Hfib for substantially high flows of industrial- and full-scale plants. Using larger electrodes in the reaction chamber would also limit the mass transfer of oxygen to the cathode due to low solubility of oxygen in the water, hence low production of Hflb and fast deterioration of cathodes. Instead using a separate electrochemical cell 130 with a small water flow enables high mass transfer of oxygen to the cathode, which enables usage of high current densities for oxygen reduction reaction, obtaining a high Hfib production rate. A high concentration of Hfib can thus be efficiently achieved before being injected into the main water stream. In such a system, small electrodes are sufficient to generate
required H2O2.
An advantage of the disclosed system is that the electrochemical cell 130, being separate from the reaction vessel 110, has an inlet 132 where clean water can be supplied. The Hfib generation can thereby take place using clean water, thus avoiding formation of potential toxic by-
products from electrochemical reactions which usually form
13
during electrochemical processes when using wastewater as a
source for Hflb generation.
Another advantage is that by using a solid-state electrolyte, handling of liquid electrolytes is avoided. Liquid electrolytes require addition of chemicals for conductivity of the electrochemical cell as well as demand extensive handling and continuous supply. Moreover, if wastewater is used as an electrolyte for generation of Hfib, a potential toxic by- product i.e., perchlorate of electrochemical process can be formed which is under strict regulation in many countries. Solid-state electrolytes such as ion exchange membranes can replace liquid electrolytes due to its convenience for practical applications. Using a solid-state electrolyte will also reduce the energy consumption of Hfib production, thus,
decrease in overall cost.
The reaction vessel llO is adapted to provide sufficient treatment time for reaction between O3 and Hflb introduced into the vessel llO for efficient treatment of water. The treatment time depends on the water quality, disinfection to be achieved and contaminants to be removed. For example, wastewater at a sewage treatment plant might require up to 45 minutes of treatment. Oil contaminated water might require a few hours of treatment and drinking water usually requires a few minutes of treatment. The reaction vessel volume is designed based on specific water to be treated to provide sufficient time for
treatment.
The outlet ll2 for gas is suited for the release of gasses
such as 03.
14
In one embodiment, the system further comprises a source 120 of 03 for providing 03to the system, the source 120 being in fluid connection with the reaction vessel 110 at least via the second vessel inlet 121. It is conceived that the source of 03 may not generate 100% pure ozone, and that there may be a mixture further comprising 02 as well as other gases. The source 120 of 03 is adapted to suit the system. The source 120 of 03 is in one embodiment an 03 generator. The source 120 of
03 is in one embodiment an 03 gas tank.
The 03 enters the reaction vessel 110 in a lower part of the reaction vessel 110, resulting in an upward flow of 03 through the reaction vessel 110 (Fig 1-5). The upward flow allows the 03 to react with water comprised in the reaction vessel 110 before exiting the reaction vessel 110 through the second vessel outlet 112. The lower part is in one embodiment the
lower 1/3, 1/4, 1/8 or 1/16 part of the reaction vessel 110.
The outlet 112 for gas is in one embodiment located in the upper 1/4, 1/8 or 1/16 part of the reaction vessel 110, such that gasses (e.g., 03) can exit from the reaction vessel 110
after flowing upwards.
In one embodiment, (Fig. 1 and 5) of the water treatment system, said second vessel inlet 121 is in fluid connection with said reaction vessel 110 through at least one diffuser 114, said at least one diffuser 114 being located in a lower part of the reaction vessel 110. The source 120 of 03 thereby
introduces 03 into a lower part of reaction vessel 110 through
at least one diffuser 114, resulting in an upward flow of 03
through the reaction vessel 110.
In one such embodiment (Fig. 1), the first vessel inlet 113 is located in an upper part of the reaction vessel 110, for example the upper 1/4, 1/8 or 1/16 part of the reaction vessel 110 and the first vessel outlet 111 is located in a lower part of the reaction vessel 110, for example the lower 1/4, 1/8 or 1/16 part of the reaction vessel 110, resulting in a downward flow of water to be treated comprising Hfib through the reaction vessel 110. The upward flow of the 03 and the simultaneous downward flow of the water comprising Hfib results in Hflb reacting with dissolved 03 to produce the desired °OH. The at least one diffuser 114 is in one embodiment a plurality of diffusers 114 spread out at different horizontal locations in the lower part, such as at the lower 1/3, 1/4, 1/8 or 1/16 part of the reaction vessel 110. In this embodiment, Hfib enters the reaction vessel 110 in an upper part. In one embodiment, this occurs as the Hfib inlet point 115 is located at a point on the main water line 150 and the main water line 150 leads into the reaction vessel 110 through first vessel inlet 113 which is located in an upper part of the reaction vessel 110 (as in Fig. 1). In another embodiment, the Hflb inlet point 115 is located at a point directly leading into the upper part of the reaction vessel 110, separately from the main water line 150. This setup allows the water to be treated to react with ozone without presence of Hfib in the reaction vessel 110 for an adaptable time period to achieve water disinfection by ozonation before Hflb is added and the peroxone
reaction takes place.
16
In another such embodiment, the first vessel inlet 113 is located in a lower part of the reaction vessel 110, for example the lower 1/4, 1/8 or 1/16 part of the reaction vessel 110 and the first vessel outlet 111 is located in an upper part of the reaction vessel 110, for example the upper 1/4, 1/8 or 1/16 part of the reaction vessel 110. Features regarding how the Hfib and ozone may enter the main water line 150 which will described below may when suitable (such as when the main water line 150 enters the reaction vessel 110 through first vessel inlet 113 at an upper part of the vessel 110) be combined with the presence of at least one diffuser 114. In one embodiment, ozone can thereby be added to the reaction vessel 110 both via the main water line 150 (optionally through a venturi injector and optionally via a first flow path 151 which will be described further below) and is also added to the reaction vessel 110 via at least one diffuser 114 located in a lower part of the reaction vessel 110. One such embodiment is shown in Fig. 5. In one such embodiment, a major part of the ozone is added via the main water line 150 and a smaller part is added via the at least one diffuser 114. In one embodiment, the system is configured such that ozone may be added from these sources at least in part simultaneously. In one embodiment, the system is configured such that ozone
may be added from these sources at different time points.
In one embodiment, (Fig. 2-5), the water treatment system further comprises at least one injection site 140 for injecting 03 into at least one first flow path 151 for water, said at least one first flow path 151 being in fluid connection with the reaction vessel 110 and having at least one first flow path inlet 116 upstream of said at least one injection site 140 and at least one first flow path outlet 119
downstream of said at least one injection site 140,
17
said at least one injection site 140 optionally comprising a
venturi injector.
In one embodiment, the cross-sectional area of the narrowest passage of the at least one first flow path 151 is smaller than the cross-sectional area of the narrowest passage of main
water line 150 (Fig. 2-5).
A venturi injector allows more ozone to be added per volume of water compared to addition of gas bubbles. Injecting ozone via a venturi injector using a side stream with a lower flow (such as the first and second flow paths 151, 152) than the main water line 150 is advantageous because injecting ozone via a venturi injector requires certain pressure which is easily managed for low flow using a small pump. Injecting the ozone into the full flow of the main water line 150 which would
require a more powerful pump and higher energy.
In one embodiment (Fig. 2), the at least one first flow path outlet 119 is located at a lower part of said reaction vessel
110,
said first vessel inlet 113 is located in an upper part of the
reaction vessel 110,
said first vessel outlet 111 is located in a lower part of the
reaction vessel 110, and
said Hflb inlet point 115 is located at a point on the main
water line 150 or at an upper part of the reaction vessel 110.
In one embodiment, the at least first flow path outlet 119
coincides with second vessel inlet 121. In one embodiment, the
18
at least one first flow path outlet 119 is located inside the reaction vessel 110. In one embodiment, a plurality of first flow path outlets 119 are spread out at different horizontal locations in the reaction vessel 110. In one embodiment, the plurality of first flow path outlets 119 are spread out at different horizontal locations in the lower 1/3, 1/4, 1/8 or 1/16 part of the reaction vessel 110. In one embodiment, the plurality of first flow path outlets 119 are spread out at different horizontal locations located below the first vessel
outlet 111 (Fig. 2).
In one embodiment (Fig. 3-5), the at least one first flow path 151 is in fluid connection, through said first flow path inlet 116, either with said main water line 150 at a point A on the
main water line 150 or with a separate source of water,
said at least first flow path outlet 119 is in fluid connection with said main water line 150 at a point B on the
main water line 150,
point B is located downstream of point A in the intended flow direction of the water in said at least one first flow path
151,
said first vessel inlet 113 is located in the lower part of
said reaction vessel 110, and
said first vessel outlet 111 is located in the upper part of
said reaction vessel 110.
In other words, the first flow path 151 can have as a source of water either the water in main water line 150 or a separate source of water. The water in first flow path 151 enters the
main line 150 at a point upstream of first vessel inlet 113.
19
This setup enables addition of ozone to the water to be
treated before introduction of Hfib into that water.
The embodiments where the ozone is injected into the main water line 150 before entering the vessel 110 are configured such that the main water line 150 enters in the lower part so that ozone enters into the reaction vessel 110 from the lower part. In these embodiments, the water flows upwards through the reaction vessel 110 as the first vessel outlet 111 is located in an upper part of the reaction vessel 110. As can be seen in Fig. 3-4, the second vessel inlet 121 for supplying 03 to the vessel and the first vessel inlet 113 for water to be treated to enter the vessel 110 may coincide. In Fig. 5, 03 is added both this way and through a separate path leading to diffusers 114.
In one embodiment, (Fig. 4-5), the water treatment system
further comprises a second flow path 152 for water,
said Hflb inlet point 115 being located at a point on said
second flow path 152,
said second flow path 152 having a second flow path inlet 122 upstream of said Hfib inlet point 115 and a second flow path
outlet 123 downstream of said Hflb inlet point 115,
said Hfib inlet point 115 optionally comprising a venturi
injector,
said second flow path 152 being in fluid connection, through said second flow path inlet 122, with said main water line 150 at a point C on the main water line 150 or with a separate
source of water,
said second flow path outlet 123 being in fluid connection with said main water line 150 at a point D on the main water
line 150, and
point D being located downstream of point C in the intended
flow direction of the water in said second flow path 152.
Such a second flow path 152 may be present in all embodiments where Hflb is introduced into the main water line 150, allowing water comprising Hfib to be introduced into a smaller stream
first.
In one embodiment, where there also is a first flow path 151 and a point B present, point C is located on said main water line 150 at a location downstream of point B in the intended
flow direction of the water in said main water line 150.
This setup also allows the water to be treated to react with ozone without presence of Hflb in the main water line 150 for an adaptable time period to achieve water disinfection by ozonation before the Hfib enters and a peroxone reaction takes place. In this embodiment, the main water line 150 enters the reaction vessel in a lower part of the reaction vessel. The lower part is in one embodiment the lower 1/3, 1/4, 1/8 or 1/16 part of the reaction vessel 110. The ozone enters the main water line 150 upstream of first vessel inlet 113, either directly or through at least one separate first flow path 151 for water configured as in the embodiments described above. In one embodiment, the ozone enters a first flow path 151 through a dosing pump. In one embodiment, the ozone enters a first
flow path 151 through a venturi injector.
21
The ozone thereby enters the reaction vessel 110 in a lower part of the reaction vessel 110. The first vessel outlet 111 for treated water to exit said reaction vessel 110 is located in the upper part of the reaction vessel 110. The second vessel outlet 112 for gas to exit said reaction vessel 110 is located in the upper part of said reaction vessel 110. This results in an upward flow of 03 through the reaction vessel
110.
The same characteristics apply for the second flow path 152 as for first flow path 151: the separate second flow path 152 may be a narrower flow path with a lesser water stream than the main water line 150. It may have the main water line 150 as a source of water, or have a separate source of water, and enter the main water line 150 upstream of the first vessel inlet 113. This is suitable when there is a high flow and pressure in the main water line 150. In one embodiment, the water comprising Hflb is introduced into the second flow path 152 using a dosing pump. In another embodiment, the Hflb inlet
point 115 comprises a venturi injector.
The different ways of introducing 03 and Hflb to the reaction vessel 110 may be combined when compatible in ways that produce additional embodiments. For example, there could be multiple paths for 03 leading into the reaction vessel 110, directly or via the main water line 150. This facilitates introducing 03 at more than one location and at more than one time point when performing water purification. In one embodiment, there is more than one first flow path 151 into
which 03 is injected.
22
In one embodiment, the water treatment system further comprises at least one static mixer 160 located in at least one of the main water line 150, or when present, a first flow path 151 and a second flow path 152. In one embodiment, the water treatment system further comprises at least one static mixer 160 located between the at least one Hflb inlet point 115 and the first vessel inlet 113. In one embodiment, the water treatment system further comprises at least one static mixer 160 located between point B and the at least one Hfib inlet point 115. Between, in this context, refers to a location
between two points with respect to the flow or water.
In one embodiment, the water treatment system further
comprises UV lamps in the reaction vessel 110.
In one embodiment, at least one of the at least one cathode and the at least one anode is a gas diffusion electrode. In one embodiment, the cathode is carbon-based. In one embodiment, the cathode is modified by catalysts. In one
embodiment, the anode is comprised of carbon or metal based.
In one embodiment, the cathode is selected from the group consisting of a graphite electrode, a glassy carbon electrode,
a carbon fibre electrode and a gas diffusion electrode.
In one embodiment, the cathode is a gas diffusion electrode selected from the group consisting of a carbon paper/cloth/felt-polytetrafluoroethylene electrode, activated carbon-polytetrafluoroethylene electrode, carbon black-
polytetrafluoroethylene electrode, carbon nanotube-
23
polytetrafluoroethylene electrode, and graphene-
polytetrafluoroethylene electrode.
In one embodiment, the cathode is shaped flat in gas diffusion
electrode configuration.
In one embodiment, the at least one anode comprises at least one material selected from the group consisting of carbon
cloth, BDD, Pt, Ru, and Ti/RuO2.
In one embodiment, the at least one anode is at least one selected from the group consisting of a Pt electrode, a boron- doped diamond electrode, a Pt/C electrode, a titanium rhodium- plated electrode, a titanium platinized electrode, a titanium based ruthenium dioxide electrode, a stainless steel electrode, a nickel electrode and an alloy electrode containing two or more transition metals, an aluminum alloy electrode, a titanium alloy electrode, a copper alloy electrode, a zinc alloy electrode, a carbon paper- polytetrafluoroethylene, a carbon cloth and a carbon black-
polytetrafluoroethylene electrode.
In one embodiment, the solid-state electrolyte comprises an ion exchange membrane. In one embodiment, it is coated with a
catalyst.
According to a second aspect, there is provided a method for
purification of water, the method comprising the steps of:
24
- supplying clean water, oxygen and electricity to at least one electrochemical cell 130, said at least one electro- chemical cell 130 comprising at least one cathode, at least one anode and a solid-state electrolyte, whereby Hflb is generated electrochemically when oxygen undergoes an oxygen
reduction reaction on the surface of the cathode,
- supplying water comprising Hflb from said electrochemical
cell 130 into a reaction vessel 110,
- supplying water to be treated into the reaction vessel 110 through a water main line 150 which enters the reaction vessel
110 through a first vessel inlet 113, - introducing O3 into a lower part of said reaction vessel 110, - releasing gas from said reaction vessel 110, and
- releasing treated water from said reaction vessel 110.
An advantage of supplying clean water, oxygen and electricity to at least one electrochemical cell 130, is the resulting Hflb generation which takes place separate from the reaction vessel 110 where an electro-peroxone reaction takes place. This gives an improved ability to provide availability of oxygen to the at least one cathode and thereby use of high current densities
using small size electrodes.
Another advantage of the method is that Hflb generation takes place using clean water, thereby avoiding formation of potential toxic by-products which usually form during
electrochemical processes when using Wastewater as a source.
By using a solid-state electrolyte in the method, handling of
liquid electrolytes is avoided.
The flow velocity of the water entering the reaction vessel llO is adapter to provide sufficient treatment time in the
reaction vessel llO for reaction between O3 and H2O2.
In one embodiment, the water comprising Hflb is supplied into the reaction vessel llO by being introduced into the main
water line 150 in which the water to be treated flows.
In one embodiment, the water comprising Hflb is supplied into the reaction vessel llO by being introduced into the reaction vessel llO separately from the main water line 150 in which
the water to be treated flows.
In all embodiments, the step of introducing O3 into the reaction vessel llO is performed such that O3 and Hfib is at some point present in the reaction vessel llO at the same time. In one embodiment, the step of introducing O3 occurs at least in part simultaneously as introducing the water comprising H2O¿ In one embodiment, the step of introducing O3 into the reaction vessel llO commences prior to introducing the water comprising Hfib. It may vary from a few seconds to a few minutes. In one embodiment, O3 is introduced at more than
one time point and/or through more than one inlet.
In one embodiment, the method further comprises:
water to be treated comprising Hflb entering said reaction
vessel llO in an upper part of said reaction vessel llO, and
treated water exiting through the first vessel outlet lll
located in a lower part of said reaction vessel llO, such that
26
a downward flow of water occurs within said reaction vessel
110, and
introducing O3 into a lower part of said reaction vessel 110, such an upward flow of O3occurs within said reaction vessel
110.
The upward flow of the 03 and the simultaneous downward flow of the water comprising Hflb results in Hflb reacting with
dissolved 03 to produce the desired °OH.
In one embodiment, the step of introducing 03 into said reaction vessel 110 comprises introducing 03 to said reaction vessel 110 through at least one diffuser 114 located in a
lower part of said reaction vessel 110.
In one embodiment, the method comprises:
introducing O3 into at least one first flow path 151 for water through at least one injection site 140, optionally through a
venturi injector, and
water with 03 entering from said at least one first flow path 151 into said reaction vessel 110 through at least one first flow path outlet 119 located in a lower part of said reaction
vessel 110.
In one embodiment, the method comprises:
introducing O3 into at least one first flow path 151 for water through at least one injection site 140, optionally through a
venturi injector,
27
water entering said at least one first flow path 151 through at least one first flow path inlet 116 and exiting through at least one first flow path outlet 119,
said first flow path inlet 116 being located such that water to be treated enters the at least one first flow path 151 from a point A on the main water line 150 or from a separate source
of water,
said at least one first flow path outlet 119 being located such that water exits from the at least one first flow path 151 and enters the main water line 150 at a point B, point B being located downstream of point A and upstream of first
vessel inlet 113 in the intended flow direction of the water,
said first vessel inlet 113 being located in the lower part of
said reaction vessel 110, and
said first vessel outlet 111 being located in the upper part
of said reaction vessel 110.
In one embodiment, 03 is introduced to the water to be treated at a time point 0-5 minutes before being mixed with water comprising Hflb. In one embodiment, 03 is introduced into the water to be treated at at least one more time point after this first mixing of water comprising 03 and with water comprising
H2O2.
In one embodiment, 03 is introduced to the water to be treated both through diffusers 114 located in a lower part of the reaction vessel 110 and through the water main line 150,
optionally through a venturi injector.
28
In one embodiment, the content of the at least one first flow path 151 is mixed before entering said reaction vessel 110, at a location downstream and/or upstream of said at least one
injection site 140.
In one embodiment of the method, the impurities to be removed from the water to be treated comprises at least one selected from the group consisting of ibuprofen, diclofenac, diazepam, iopromide, methotrexate, primidone, chloranilic acid, 2-(methylthio)-benzothiazole (MTBT), cetirizine, clindamycin, ranitidine, diclofenac, sulfamethoxazole, carbamazepine, trimethoprim, terbutaline, erythromycin, naproxen, norfloxacin, ciprofloxacin, clotrimazole, codeine, clarithromycin, bisoprolol, atorvastatin, flecainide, fexofenadine, tramadol, metoprolol, atenolol, mirtazapine, citalopram, methyl-benzotriazole, miconazole, propiconazole, metronidazole, ketoconazole, bupropion, 1H-benzotriazole, pentamidine, loratadine, irbesartan, oxazepam, fluconazole, and other pharmaceuticals, quaternary ammonium compounds, 2- methylisoborneol, geosminbenzoic acids, clofibric acid, oxalic acid,1,4-dioxane, bezafibrate, phthalates, petroleum products, polycyclic aromatic hydrocarbon , polychlorinated biphenyls , dyes, hydrocarbons, tolune, pesticides, surfactants, biocides, solvents, tetrachloroethylene, tricholoroethylene, benzene,
phenols, xylene, ethyl benzene, pathogens.
There are many other examples of impurities which could be removed using this method, such as those mentioned in the articles (Huijiao Wanga, Majid Mustafa, Gang Yu, Marcus Östman, Yi Chenga, Yujue Wang, Mats Tysklind. Oxidation of emerging biocides and antibiotics in Wastewater by ozonation
and the electro-peroxone process. Chemospere, Volume 235,
29
November 2019) and (Jerker Fick, Richard H. Lindberg, Mats Tysklind, D.G. Joakim Larsson. Predicted critical environmental concentrations for 500 pharmaceuticals. Regulatory Toxicology and Pharmacology 58 (2010) 516-523). The articles are incorporated herein in their entirety by
reference.
In one embodiment of the method, the water to be treated is at least one selected from sewage after secondary treatment, industrial Wastewater, car wash Wastewater, groundwater,
surface water, and drinking water.
In one embodiment of the method, drinking water is produced.
In one embodiment of the method, the water in the reaction
vessel 110 is UV treated.
The system is suitable to be used to perform the method described herein.
Claims (33)
- l. A water treatment system for purification of water, said system comprising: a. a reaction vessel (llO) comprising - a first vessel inlet (ll3) for water to be treated to enter said reaction vessel (llO), - a first vessel outlet (lll) for treated water to exit said reaction vessel (llO), - a second vessel outlet (ll2) for gas to exit said reaction vessel (llO), said second outlet (ll2) being located in an upper part of said reaction vessel (llO), and - a second vessel inlet (l2l) for supplying O3 to the reaction vessel (llO), said second inlet (l2l) being located in a lower part of said reaction vessel (llO), b. a main water line (l50) leading from a main inlet ll8 for water to be treated to said first vessel inlet (ll3), and c. an electrochemical cell (l30) for Hflb generation comprising at least one cathode, at least one anode and a solid-state electrolyte, said electrochemical cell (l30) having an oxygen inlet l3l and a clean water inlet (l32), said electrochemical cell (l30) being adapted to be connected with a source of electricity (l33), and said electrochemical cell having an outlet enabling said electrochemical cell (l30) to be in fluid connection with said reaction vessel (llO) through at least one Hfib inlet point (ll5).
- 2. The water treatment system according to claim 1, wherein said system further comprises a source (120) of O3 for providing O3to the system, the source (120) being in fluid connection with the reaction vessel (110) at least via said second vessel inlet (121).
- 3. The water treatment system according to any of claims 1-2, wherein said second vessel inlet (121) is in fluid connection with said reaction vessel (110) through at least one diffuser (114), said at least one diffuser (114) being located in a lower part of the reaction vessel (110).
- 4. The water treatment system according to any of claims 1-3, further comprising at least one injection site (140) for injecting O3 into at least one first flow path (151) for water, said at least one first flow path (151) being in fluid connection with the reaction vessel (110) and having at least one first flow path inlet (116 ) upstream of said at least one injection site (140) and at least one first flow path outlet (119) downstream of said at least one injection site, said at least one injection site (140) optionally comprising a venturi injector.
- 5. The water treatment system according to claim 4, wherein the cross-sectional area of the narrowest passage of the at least one first flow path (151) is smaller than the cross-sectional area of the narrowest passage of main water line (150).
- 6. The water treatment system according to any of claims 4-5, said at least one first flow path outlet (119)being located in a lower part of said reaction vessel (110), and said first vessel inlet (113) being located in an upper part of the reaction vessel (110), said first vessel outlet (111) being located in a lower part of the reaction vessel (110), and said Hflb inlet point (115) being located at a point on the main water line (150) or at an upper part of the reaction vessel (110).
- 7. The water treatment system according to any of claims 3-5, said at least one first flow path (151) being in fluid connection, through said first flow path inlet (116 ), either with said main water line (150) at a point A on the main water line (150) or with a separate source of water, said at least one first flow path outlet (119) being in fluid connection with said main water line (150) at a point B on the main water line (150), point B being located downstream of point A in the intended flow direction of the water in said at least one first flow path (151), said first vessel inlet (113) being located in the lower part of said reaction vessel (110), and said first vessel outlet (111) being located in the upper part of said reaction vessel (110).
- 8. The water treatment system according to any of claims 1-7 further comprising a second flow path (152) for water,said Hflb inlet point (115) being located at a point on said second flow path (152), said second flow path (152) having a second flow path inlet (122) upstream of said Hfib inlet point (115) and a second flow path outlet (123) downstream of said Hflb inlet point (115), said Hfib inlet point (115) optionally comprising a venturi injector, said second flow path (152) being in fluid connection, through said second flow path inlet (122), with said main water line (150) at a point C on the main water line (150) or with a separate source of water, said second flow path outlet (123) being in fluid connection with said main water line (150) at a point D on the main water line (150), and point D being located downstream of point C in the intended flow direction of the water in said second flow path (152).
- 9. The water treatment system according to claim 8 and 7, point C being located downstream of point B in the intended flow direction of the water in said main water line (150).
- 10. The water treatment system according to any of claims 1-9, further comprising at least one static mixer (160) located in at least one of: the main water line (150), a first flow path (151) and a second flow path (152).
- 11. The water treatment system according to any of claims 1-19, wherein at least one static mixer (160) islocated between the at least one Hfib inlet point (115) and the first vessel inlet (113).
- 12. The water treatment system according to any of claim 7-11 wherein at least one static mixer (160) is located between point B and the at least one Hfib inlet point (115).
- 13. The water treatment system according to any of claim 1-12, further comprising UV lamps in the reaction vessel (110).
- 14. The water treatment system according to any of claims 1-13, wherein at least one of the at least one cathode and the at least one anode is a gas diffusion electrode.
- 15. The water treatment system according to any of claims 1-14, wherein the cathode is selected from the group consisting of a graphite electrode, a glassy carbon electrode, a carbon fiber electrode and a gas diffusion electrode.
- 16. The water treatment system according to any of claims 1-15, wherein the cathode is a gas diffusion electrode selected from the group consisting of a carbon paper/cloth/felt-polytetrafluoroethylene electrode, activated carbon-polytetrafluoroethylene electrode, carbon black- polytetrafluoroethylene electrode, carbon nanotube- polytetrafluoroethylene electrode, and graphene- polytetrafluoroethylene electrode.
- 17. The water treatment system according to any of claims 1-16, wherein the cathode is shaped flat in gas diffusion electrode configuration.
- 18. The water treatment system according to any of claims 1-17, wherein the at least one anode comprises at least one material selected from the group consisting of carbon cloth, BDD, Pt, Ru, and Ti/RuO
- 19. A method for purification of water, the method comprising the steps of: - supplying clean water, oxygen and electricity to at least one electrochemical cell (130), said at least one electro- chemical cell (130) comprising at least one cathode, at least one anode and a solid-state electrolyte, whereby Hflb is generated in situ electrochemically when oxygen undergoes an oxygen reduction reaction on the surface of the cathode, - supplying water comprising Hflb from said electrochemical cell (130) into a reaction vessel (110), - supplying water to be treated into the reaction vessel (110) through a water main line (150) which enters the reaction vessel (110) through a first vessel inlet (113), - introducing O3 into a lower part of said reaction vessel (110), - releasing gas from said reaction vessel (110), and - releasing treated water from said reaction vessel (110).
- 20. The method for purification of water according to claim, 19, wherein the water comprising Hfib is supplied intothe reaction vessel (110) by being introduced into the main water line (150) in which the water to be treated flows.
- 21. The method for purification of water according to any of claims 19-20, wherein the water comprising Hflb is supplied into the reaction vessel (110) by being introduced into the reaction vessel (110) separately from the main water line (150) in which the water to be treated flows.
- 22. The method for purification of water according to any of claims 19-21, the method further comprising: - water to be treated comprising Hflb entering said reaction vessel (110) in an upper part of said reaction vessel (110), and - treated water exiting through the first vessel outlet (111) located in a lower part of said reaction vessel (110), such that a downward flow of water occurs within said reaction vessel (110), and - introducing 03 into a lower part of said reaction vessel (110), such an upward flow of 03occurs within said reaction vessel (110).
- 23. The method for purification of water according to any of claims 19-22, wherein the step of introducing 03 into said reaction vessel (110) comprises introducing 03 to said reaction vessel (110) through at least one diffuser (114) located in a lower part of said reaction vessel (110).
- 24. The method for purification of water according to any of claims 19-22, the method comprising:- introducing O3 into a first flow path (151) for water through at least one injection site (140), optionally through a venturi injector, and - water with O3 entering from said first flow path (151) into said reaction vessel (110) through at least one first flow path outlet (119) located in a lower part of said reaction vessel (110).
- 25. The method for purification of water according to any of claims 19-23, the method comprising: - introducing O3 into a first flow path (151) for water through at least one injection site (140), optionally through a venturi injector, - water entering said first flow path (151) through at least one first flow path inlet (116 ) and exiting through at least one first flow path outlet (119), said first flow path inlet (116 ) being located such that water to be treated enters the first flow path (151) from at a point A on the main water line (150) or from a separate source of water, said at least one first flow path outlet (119) being located such that water exits from the first flow path (151) and enters the main water line (150) at a point B, point B being located downstream of point A and upstream of first vessel inlet (113) in the intended flow direction of water, said first vessel inlet (113) being located in the lower part of said reaction vessel (110), and said first vessel outlet (111) being located in the upper part of said reaction vessel (110).26. The method for purification of water according to any of claims 19-21 and 23-25, when not dependent on claim 22, wherein 03 is introduced to the water to be treated at a time point 0-5 minutes before being mixed with water comprising
- H2O
- 27. The method according to any of claims 19-26, wherein the content of main water line (150) is mixed before entering said reaction vessel (110), at a location downstream and/or upstream of said at least one injection site (140).
- 28. The method according to any of claims 24-27, wherein the content of first flow path (151) is mixed before entering said reaction vessel (110), at a location downstream and/or upstream of said at least one injection site (140).
- 29. The method according to any one of claims 19-28, wherein the impurities comprise at least one selected from the group consisting of ibuprofen, diclofenac, diazepam, iopromide, methotrexate, primidone, chloranilic acid, 2-(methylthio)-benzothiazole (MTBT), cetirizine, clindamycin, ranitidine, diclofenac, sulfamethoxazole, carbamazepine, trimethoprim, terbutaline, erythromycin, naproxen, norfloxacin, ciprofloxacin, clotrimazole, codeine, clarithromycin, bisoprolol, atorvastatin, flecainide, fexofenadine, tramadol, metoprolol, atenolol, mirtazapine, citalopram, methyl-benzotriazole, miconazole, propiconazole, metronidazole, ketoconazole, bupropion, 1H-benzotriazole, pentamidine, loratadine, irbesartan, oxazepam, fluconazole, and other pharmaceuticals, quaternary ammonium compounds, 2- methylisoborneol, geosminbenzoic acids, clofibric acid, oxalic acid,1,4-dioxane, bezafibrate, phthalates, petroleum products,polycyclic aromatic hydrocarbon, polychlorinated biphenyls, dyes, hydrocarbons, tolune, pesticides, surfactants, biocides, solvents, tetrachloroethylene, tricholoroethylene, benzene, phenols, xylene, ethyl benzene, pathogens.
- 30. The method according to any one of claims 19-29, wherein the water to be treated is at least one selected from sewage after secondary treatment, industrial Wastewater, car wash Wastewater, groundwater, surface water, and drinking water.
- 31. The method according to any one of claims 19-30, wherein drinking water is produced.
- 32. The method for purification of water according to any of claims 19-31, wherein the method is performed using a system according to any one of claims 1-
- 33. The method for purification of water according to any of claims 19-32, wherein the water in the reaction vessel (110) is UV treated.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE2251224A SE2251224A1 (en) | 2022-10-19 | 2022-10-19 | Water purification involving an electro-peroxone process |
DE102023128362.6A DE102023128362A1 (en) | 2022-10-19 | 2023-10-17 | WATER PURIFICATION USING AN ELECTRO-PEROXON PROCESS |
FI20236156A FI20236156A1 (en) | 2022-10-19 | 2023-10-18 | Water purification involving an electro-peroxone process |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE2251224A SE2251224A1 (en) | 2022-10-19 | 2022-10-19 | Water purification involving an electro-peroxone process |
Publications (1)
Publication Number | Publication Date |
---|---|
SE2251224A1 true SE2251224A1 (en) | 2024-04-20 |
Family
ID=90573056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE2251224A SE2251224A1 (en) | 2022-10-19 | 2022-10-19 | Water purification involving an electro-peroxone process |
Country Status (3)
Country | Link |
---|---|
DE (1) | DE102023128362A1 (en) |
FI (1) | FI20236156A1 (en) |
SE (1) | SE2251224A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090114532A1 (en) * | 2007-11-06 | 2009-05-07 | Rhodes Christopher P | Cathodic Electrocatalyst Layer for Electrochemical Generation of Hydrogen Peroxide |
CA2890954A1 (en) * | 2012-12-03 | 2014-06-12 | Axine Water Technologies Inc. | Efficient treatment of wastewater using electrochemical cell |
KR20190120837A (en) * | 2018-04-11 | 2019-10-25 | 대구대학교 산학협력단 | Apparatus for purifying water based on electro-peroxone reaction |
WO2021211231A2 (en) * | 2020-03-10 | 2021-10-21 | Gradiant Corporation | Carbon-coated, transition-metal electrodes for advanced oxidation reactors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104609532B (en) | 2015-02-11 | 2017-05-24 | 清华大学 | Method for removing PPCPs in treatment process of drinking water |
ES2870615T3 (en) | 2016-03-17 | 2021-10-27 | Hpnow Aps | Electrochemical cell for gas phase reagent in liquid environment |
JP6921503B2 (en) | 2016-11-04 | 2021-08-18 | 株式会社東芝 | Water treatment equipment, water treatment system and water treatment method |
-
2022
- 2022-10-19 SE SE2251224A patent/SE2251224A1/en unknown
-
2023
- 2023-10-17 DE DE102023128362.6A patent/DE102023128362A1/en active Pending
- 2023-10-18 FI FI20236156A patent/FI20236156A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090114532A1 (en) * | 2007-11-06 | 2009-05-07 | Rhodes Christopher P | Cathodic Electrocatalyst Layer for Electrochemical Generation of Hydrogen Peroxide |
CA2890954A1 (en) * | 2012-12-03 | 2014-06-12 | Axine Water Technologies Inc. | Efficient treatment of wastewater using electrochemical cell |
KR20190120837A (en) * | 2018-04-11 | 2019-10-25 | 대구대학교 산학협력단 | Apparatus for purifying water based on electro-peroxone reaction |
WO2021211231A2 (en) * | 2020-03-10 | 2021-10-21 | Gradiant Corporation | Carbon-coated, transition-metal electrodes for advanced oxidation reactors |
Non-Patent Citations (1)
Title |
---|
Yang et al. "Evaluation of the technoeconomic feasibility of electrochemical hydrogen peroxide production for decentralized water treatment". Front. Environ. Sci. Eng. 2021, 15(1): 1 * |
Also Published As
Publication number | Publication date |
---|---|
FI20236156A1 (en) | 2024-04-20 |
DE102023128362A1 (en) | 2024-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6355818B2 (en) | Resource recycling type industrial wastewater treatment method and apparatus using oxidant produced using wastewater | |
Hübner et al. | Options and limitations of hydrogen peroxide addition to enhance radical formation during ozonation of secondary effluents | |
CA2733834C (en) | Apparatus and method for dissolution of ozone in water and catalytic oxidation | |
Escalona et al. | Fenton coupled with nanofiltration for elimination of Bisphenol A | |
Helble et al. | Advanced effluent treatment in the pulp and paper industry with a combined process of ozonation and fixed bed biofilm reactors | |
Lima et al. | Gaseous and liquid effluents treatment in bubble column reactors by advanced oxidation processes: A review | |
US20170333850A1 (en) | Fluid distribution device for a gas-liquid contactor, gas-liquid contactor and method for adding a gas to a liquid | |
CN102381791A (en) | Equipment for treating organic wastewater through joint of electrolyzation and oxidant | |
Zou et al. | A novel persulfate-photo-bioelectrochemical hybrid system promoting the degradation of refractory micropollutants at neutral pH | |
KR102052039B1 (en) | Apparatus for purifying water based on electro-peroxone reaction | |
US20230018120A1 (en) | Regulation of on-site electrochemical generation of hydrogen peroxide for ultraviolet advanced oxidation process control | |
SE2251224A1 (en) | Water purification involving an electro-peroxone process | |
Li et al. | Enhancing hydroxyl radical production from cathodic ozone reduction during the ozone-electrolysis process with flow-through reactive electrochemical membrane cathode | |
KR100564062B1 (en) | The apparatus for hybrid mediated oxidation of destroying organic wastes | |
TW200936514A (en) | Method and apparatus for treating organic-containing water | |
Ren et al. | Electrochemical oxidation of reverse osmosis concentrate using a pilot-scale reactive electrochemical membrane filtration system: Performance and mechanisms | |
KR100564055B1 (en) | Apparatus for Hybrid Mediated Oxidation of Destroying Organic Wastes by Electrochemical and Ozone Oxidation | |
KR102613581B1 (en) | An apparatus and method for treating waste water containing non-de gradable organic material | |
Al-Enezi et al. | Total organic carbon reduction of phenol-containing wastewaters by oxidation techniques | |
JP3145582B2 (en) | Method and apparatus for removing oxidized nitrogen | |
JP3543531B2 (en) | Pressurized ozone treatment equipment | |
Yang et al. | Energy-efficient treatment of refractory industrial effluent using flow-through electrochemical processes: Oxidation mechanisms and reduction of chlorinated byproducts | |
de Lima | Simultaneous Treatment of Gaseous and Liquid Streams Containing Organic Compounds By Fenton's Oxidation | |
Hirpara et al. | Ibuprofen Removal by Electrochemically Activated Peroxymonosulfate Using Iron Electrolysis: Reaction Kinetics, Optimization Using Response Surface Methodology, and Performance in Continuous Flow Mode | |
KR20240014182A (en) | Wastewater treatment apparatus producing oxidizing agent and treating organic pollutants and wastewater treatment method using the same |